Location History:
- Outwood, GB (1983 - 1989)
- Epsom, GB (1991 - 1999)
- Surrey, GB (2000)
Company Filing History:
Years Active: 1983-2000
Title: Roderick J Dorgan: Innovator in Anthelmintic Compounds
Introduction
Roderick J Dorgan is a notable inventor based in Epsom, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for the treatment of helminthiasis in humans and animals. With a total of 9 patents to his name, Dorgan's work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents is the invention of Pyrido(3,2,1-ij)-1,3,4-benzoxadiazine, which focuses on anthelmintic milbemycins and avermectins. This patent describes novel compounds of formula (I) that include various organic radicals and functional groups. These compounds are designed to be useful in treating helminthiasis, showcasing Dorgan's commitment to advancing healthcare solutions.
Career Highlights
Throughout his career, Roderick J Dorgan has worked with prominent companies such as Beecham Group Plc and Pfizer Corporation. His experience in these leading pharmaceutical firms has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.
Collaborations
Dorgan has collaborated with notable colleagues, including Geoffrey H Baker and Rhona Mary Banks. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Roderick J Dorgan's contributions to the field of pharmaceuticals, particularly through his patents and collaborations, highlight his role as a significant inventor. His work continues to influence the treatment of helminthiasis, demonstrating the importance of innovation in healthcare.